Pfizer Inc's Greenstone LLC is recalling two of its drugs, Citalopram and Finasteride, because the bottles may have been labeled incorrectly.
The company says bottles of Citalopram, a depression drug, may have been labeled inaccurately as Finasteride, used to treat benign prostatic hyperplasia, and vice versa. Finasteride is dangerous to pregnant women due to risks of side effects that can cause fetal abnormalities to the external genitalia of a developing male fetus. Citalopram patients who discontinue Citalopram abruptly by inadvertently taking the mislabeled product may experience discontinuation symptoms and/or worsening of depression.
The recalled bottles of Citalopram and Finasteride are marked with lot number FI0510058-A on the label.
The attorneys at Messa & Associates are experienced at handling cases involving pharmaceutical and drug product injuries. Our extremely skilled team of attorneys and medical experts has successfully pursued litigation and obtained verdicts and settlements for victims of pharmaceutical injuries. If you or a loved one is suffering from serious injuries as a result of ingesting drugs from the mislabeled bottles of Citalopram and Finasteride, please contact us at 1-877-MessaLaw.
No comments:
Post a Comment